Similar articles for PMID: 16359895

Year	Number of Results
1991	1
1996	7
1997	1
1999	3
2000	1
2001	4
2002	4
2003	2
2004	4
2005	8
2006	9
2007	4
2008	3
2009	5
2010	3
2011	1
2012	3
2013	1
2015	1
2016	1
2018	1
2021	1
2024	0

1

Prulifloxacin: a new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis.

Cazzola M, Salvatori E, Dionisio P, Allegra L. Cazzola M, et al. Pulm Pharmacol Ther. 2006;19 Suppl 1:30-7. doi: 10.1016/j.pupt.2005.09.007. Epub 2005 Dec 15. Pulm Pharmacol Ther. 2006. PMID: 16359895 Review.

2

Prulifloxacin.

Keam SJ, Perry CM. Keam SJ, et al. Drugs. 2004;64(19):2221-34; discussion 2235-6. doi: 10.2165/00003495-200464190-00005. Drugs. 2004. PMID: 15456336 Clinical Trial.

3

Prulifloxacin: a new antibacterial fluoroquinolone.

Prats G, Rossi V, Salvatori E, Mirelis B. Prats G, et al. Expert Rev Anti Infect Ther. 2006 Feb;4(1):27-41. doi: 10.1586/14787210.4.1.27. Expert Rev Anti Infect Ther. 2006. PMID: 16441207 Review.

4

Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.

Blasi F, Schaberg T, Centanni S, Del Vecchio A, Rosignoli MT, Dionisio P. Blasi F, et al. Pulm Pharmacol Ther. 2013 Oct;26(5):609-16. doi: 10.1016/j.pupt.2013.03.014. Epub 2013 Mar 26. Pulm Pharmacol Ther. 2013. PMID: 23538168 Clinical Trial.

5

Pharmacologic characteristics of prulifloxacin.

Matera MG. Matera MG. Pulm Pharmacol Ther. 2006;19 Suppl 1:20-9. doi: 10.1016/j.pupt.2005.09.009. Epub 2005 Dec 19. Pulm Pharmacol Ther. 2006. PMID: 16360331 Review.

6

Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis.

Grassi C, Salvatori E, Rosignoli MT, Dionisio P; Prulifloxacin Study Group. Grassi C, et al. Respiration. 2002;69(3):217-22. doi: 10.1159/000063623. Respiration. 2002. PMID: 12097764 Clinical Trial.

7

Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis.

Blasi F, Aliberti S, Tarsia P, Santus P, Centanni S, Allegra L. Blasi F, et al. Int J Chron Obstruct Pulmon Dis. 2007;2(1):27-31. doi: 10.2147/copd.2007.2.1.27. Int J Chron Obstruct Pulmon Dis. 2007. PMID: 18044063 Free PMC article. Review.

8

Prulifloxacin versus ciprofloxacin in the treatment of adults with complicated urinary tract infections.

Carmignani G, De Rose AF, Olivieri L, Salvatori E, Rosignoli MT, Dionisio P. Carmignani G, et al. Urol Int. 2005;74(4):326-31. doi: 10.1159/000084432. Urol Int. 2005. PMID: 15897698 Clinical Trial.

9

Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.

Tomii Y, Ozaki M, Matsuda M, Honmura T, Nishimura I, Yamaguchi R, Adachi T, Okawa Y, Nishino T. Tomii Y, et al. Arzneimittelforschung. 1996 Dec;46(12):1169-73. Arzneimittelforschung. 1996. PMID: 9006794

10

Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.

Giannarini G, Tascini C, Selli C. Giannarini G, et al. Future Microbiol. 2009 Feb;4(1):13-24. doi: 10.2217/17460913.4.1.13. Future Microbiol. 2009. PMID: 19207096 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

63 results

Results by year